H15.121

Clinical Causes: Unknown precise cause, but linked to autoimmune responses where the body's immune system mistakenly targets eye tissues. Associated with systemic autoimmune diseases such as rheumatoid arthritis or lupus. Potential triggers include minor eye injuries, infections, or allergic reactions, although these are less common causes. Genetic predisposition in some individuals may contribute to susceptibility. Environmental factors like exposure to irritants or pollutants may play a role.

Key Symptoms: Localized redness in the affected eye, often appearing as a segmental area of inflamed tissue. Presence of a firm, tender, nodular swelling on the episcleral surface. Discomfort or mild pain in the affected eye, especially when moving the eye or in response to touch. Sensitivity to light (photophobia). Possible tearing or watery eyes. The inflammation is typically limited in scope and tends to affect only one eye. The condition usually does not significantly impair vision.

Diagnosis Path: Diagnosis of nodular episcleritis is primarily based on clinical examination. An eye care professional will observe the characteristic nodular inflammation and redness, often using a slit lamp to differentiate it from other eye conditions like scleritis or conjunctivitis. Additional tests may include:

Treatment Protocols: Topical anti-inflammatory medications, such as corticosteroid eye drops, to reduce inflammation. Use of lubricating eye drops to soothe irritation and comfort the eye. Warm compresses applied to the affected area to help decrease swelling. Oral anti-inflammatory drugs may be considered if inflammation is extensive or persistent, under medical supervision. Monitoring and follow-up are crucial to ensure resolution and reduce risk of recurrence. Addressing any underlying systemic autoimmune condition with appropriate medical management.